Share
1,251 Posts.
lightbulb Created with Sketch. 94
clock Created with Sketch. 30/05/24
13:11
Share
Originally posted by TitusPullo:
↑
"Pro Medicus's five new contracts should underpin accelerating revenue growth into the imaging-tech provider's 2025 fiscal year, Goldman Sachs analysts tell clients in a note. They still anticipate 27% growth in fiscal 2024 revenue, but they lift their forecast for fiscal 2025 revenue growth to 32% from 30%. The GS analysts observe that the announced contract sizes contain no direct component from either AI or cardiology, which they suspect points to further potential upside over the medium term. GS raises its target price 1.5%, to A$136.00, and keeps a "buy" rating on the stock, which is at A$114.31 ahead of the open."
Expand
We're doing better today than after the announcement yesterday. Maybe a bit of a hangover?
(20min delay)